TP53 and KRAS mutations are thought to be key events in clonal spread in the IBD mucosa, but although we do observe a number of canonical cancer driver mutations in genes including TP53 and KRAS, only ARID1A and FBXW7 show significant evidence of positive selection. The gene discussed is KRAS; the disease is inflammatory bowel disease.